(Q40591981)

21 September 2017

Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation (English)

1 reference

21 September 2017

1 reference

9

Deborah A Kuban

1 reference

21 September 2017

5

Lawrence B Levy

1 reference

21 September 2017

3

Louis L Pisters

1 reference

21 September 2017

1

Charles J Rosser

1 reference

21 September 2017

Motoyoshi Tanaka

2

1 reference

21 September 2017

Noriyoshi Tanaka

4

1 reference

21 September 2017

David C Hoover

6

1 reference

21 September 2017

H Barton Grossman

7

1 reference

21 September 2017

Timothy J McDonnell

8

1 reference

21 September 2017

Raymond E Meyn

10

1 reference

21 September 2017

1 April 2004

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

273-279

1 reference

21 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700673

21 September 2017

0 references

cites work

Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

Mechanism of activation and function of protein kinase B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

inferred from DOI database lookup

7 January 2021

based on heuristic

p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700673

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700673

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference